The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Ganglionic Acetylcholine Receptor Autoantibody: Oncological, Neurological, and Serological Accompaniments
Open accessAbstract
OBJECTIVE: To describe the clinical utility of the nicotinic ganglionic acetylcholine receptor (alpha3-AChR) autoantibody as a marker of neurological autoimmunity and cancer. DESIGN: Case-control study. SETTING: Mayo Clinic, Rochester, Minnesota. PATIENTS: A total of 15,000 patients seen at Mayo Clinic (2005-2007) and evaluated on a service basis for paraneoplastic neurological autoimmunity for whom clinical information was obtained retrospectively by medical record review as well as 457 neurologically asymptomatic patients or control subjects of whom 173 were healthy, 245 had lung cancer, and 39 had systemic lupus erythematosus or Sjögren syndrome. OUTCOME MEASURES: Neurological, oncological, and serological associations of alpha3-AChR autoantibody seropositivity. RESULTS: Of 15,000 patients tested on a service basis, 1% were seropositive (median, 0.12 nmol/L; range, 0.03-18.8 nmol/L; normal, < or =0.02 nmol/L), 55% were male, and the median age was 65 years. Cancer was found (new or by history) in 24 of 78 patients evaluated for cancer while at Mayo Clinic (30%); 43% had adenocarcinoma (more patients had breast cancer than prostate, lung, and gastrointestinal cancers; each of the latter groups had about the same number of patients). Of 12 patients with high antibody values (> or =1.00 nmol/L), 83% had pandysautonomia. Of 85 patients with medium antibody values (0.10-0.99 nmol/L), neurological presentations were more diverse and included peripheral neuropathies (36%), dysautonomia (20%, usually limited), and encephalopathy (13%). Of 58 patients with low antibody values (0.03-0.09 nmol/L), 54% had a nonautoimmune neurological disorder or no neurological disorder. Of 245 control patients with lung cancer, 7.8% were seropositive. Only 1 of 212 control patients without cancer (0.5%) was seropositive (P < .001). CONCLUSION: The detection of alpha3-AChR autoantibody aids the diagnosis of neurological autoimmunity and cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Seropositivity for antiganglionic acetylcholine receptor antibodies is the serological hallmark of autoimmune autonomic ganglionopathy.”
From 2018 ESC Guidelines for the diagnosis and management of syncope (2018) · cites this paper as [434]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A polymorphic DNA marker genetically linked to Huntington's disease
Gusella, J. F., Wexler, N. S., Conneally, P. M., Naylor, S. L., Anderson, M. A., Tanzi, R. E., Watkins, P. C., Ottina, K. A., Wallace, M. R., Sakaguchi, A. Y., et al. (1983) · Nature · doi:10.1038/306234a0 · Cited by 2,340
Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies
Vernino, S., Low, P. A., Fealey, R. D., Stewart, J. D., Farrugia, G., & Lennon, V. A. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009213431204 · Cited by 674
Self-citationPostural orthostatic tachycardia syndrome: the Mayo clinic experience
Thieben, M. J., Sandroni, P., Sletten, D. M., Benrud-Larson, L. M., Fealey, R. D., Vernino, S., Low, P. A., Lennon, V. A., & Shen, W.-K. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)61027-6 · Cited by 516
Self-citationComposite Autonomic Scoring Scale for Laboratory Quantification of Generalized Autonomic Failure
Low, P. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60631-4 · Cited by 466
Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome
Pittock, S. J., Kryzer, T. J., & Lennon, V. A. (2004) · Annals of Neurology · doi:10.1002/ana.20269 · Cited by 318
Self-citationHeterogeneity and complexity of native brain nicotinic receptors
Gotti, C., Moretti, M., Gaimarri, A., Zanardi, A., Clementi, F., & Zoli, M. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.05.023 · Cited by 282
Thermoregulatory Sweating Abnormalities in Diabetes Mellitus
Fealey, R. D., Low, P. A., & Thomas, J. E. (1989) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65338-5 · Cited by 274
Self-citationGlutamic Acid Decarboxylase Autoimmunity With Brainstem, Extrapyramidal, and Spinal Cord Dysfunction
Pittock, S. J., Yoshikawa, H., Ahlskog, J. E., Tisch, S. H., Benarroch, E. E., Kryzer, T. J., & Lennon, V. A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.9.1207 · Cited by 231
Self-citationVernino, S. A., Adamski, J., Kryzer, T. J., Fealey, R. D., & Lennon, V. A. (1998) · Neurology · doi:10.1212/wnl.50.6.1806 · Cited by 226
Self-citationImmunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease
Lennon, V. A., Ermilov, L. G., Szurszewski, J. H., & Vernino, S. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17429 · Cited by 178
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- [15]Griesmann G Kryzer TJ Lennon VA Rose N Hamilton RG Detrick B Autoantibody profiles of myasthenia gravis and Lambert-Eaton myasthenic syndrome Manual of Clinical Laboratory Immunology Washington, DC ASM Press 2002 1005 1012
Cited by
Sorted by citations
Items 101–167 of 167
Nagata, R., Matsuura, E., Nozuma, S., Dozono, M., Noguchi, Y., Ando, M., Hiramatsu, Y., Kodama, D., Tanaka, M., Kubota, R., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1137958 · Cited by 5
Beyond the Glands: An in-Depth Perspective of Neuropathy in Sjögren’s Syndrome
Voigt, A. (2014) · Rheumatology Current Research · doi:10.4172/2161-1149.s4-010 · Cited by 5
FDG-PET/CT in the evaluation of paraneoplastic neurologic syndromes
Sherry, S. J., Tahari, A. K., Mirpour, S., Colucci, A. T., & Subramaniam, R. M. (2014) · Imaging in Medicine · doi:10.2217/iim.13.73 · Cited by 4
Paraneoplastic neuropathies and peripheral nerve hyperexcitability disorders
Shelly, S., Dubey, D., Mills, J. R., & Klein, C. J. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00020-7 · Cited by 4
Noaiseh, G., Deboo, A., King, J. K., Varadhachary, A. S., Sarka, G., Goodman, B. P., Hammitt, K. M., Frantsve‐Hawley, J., Fox, R. I., Baker, M. C., et al. (2024) · Arthritis & Rheumatology · doi:10.1002/art.43050 · Cited by 4
Neuropsychiatric Systemic Lupus Erythematosus: Mechanisms of Injury
Mackay, M. C., Uluğ, A. M., & Volpe, B. T. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-374994-9.10028-2 · Cited by 4
Management of Immune-Mediated Paraneoplastic Neurological Disorders
Ayzenberg, I., Gold, R., & Kleiter, I. (2017) · Neurology International Open · doi:10.1055/s-0043-112730 · Cited by 4
Leal, C. D. R., Lage-Sánchez, J. M., Ríos, J. P., Plaza, O. L., Hamad-Cueto, O., de Vera, M. T. D., & Dawid-Milner, M. S. (2022) · Neurological Sciences · doi:10.1007/s10072-022-06075-y · Cited by 5
Epidemiology of paraneoplastic neurologic syndromes
Kadish, R., & Clardy, S. L. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00011-6 · Cited by 4
Garg, A., Chedrawi, A. K., Pardo, C. A., Johnston, M., & Menon, D. U. (2015) · Journal of Pediatric Neurology · doi:10.3233/jpn-140658 · Cited by 4
Alpha 3 ganglionic acetylcholine receptor antibody associated refractory status epilepticus
Bansal, P., Zutshi, D., Suchdev, K., Azher, I., & Mohamed, W. (2015) · Seizure · doi:10.1016/j.seizure.2015.12.008 · Cited by 4
Paraneoplastic Neurological Syndromes
Muñiz‐Castrillo, S., & Honnorat, J. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_14 · Cited by 4
Erkrankungen des autonomen Nervensystems
Haubrich, C. (2020) · Springer Reference Medizin · doi:10.1007/978-3-662-60676-6_65 · Cited by 4
Paraneoplastic Neurologic Syndromes
Rauschkolb, P. K., & Posner, J. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-384929-8.00058-7 · Cited by 4
Reader response: Unintended consequences of Mayo paraneoplastic evaluations
Pittock, S. J., Mills, J. R., & McKeon, A. B. (2019) · Neurology · doi:10.1212/wnl.0000000000008179 · Cited by 4
Self-citationMikkelsen, A. W., Nilsson, A. C., Tenstad, H. B., Lillevang, S. T., & Asgari, N. (2024) · Thoracic Cancer · doi:10.1111/1759-7714.15318 · Cited by 3
Wide range of clinicopathological features in immune‐mediated autonomic neuropathies
Koike, H., & Sobue, G. (2013) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12003 · Cited by 3
Acute Bilateral Tonic Pupil in a Child
Brandner, M., Hubmann, H., & Langmann, A. (2017) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2017.2304 · Cited by 3
Paraneoplastic autonomic neuropathies and GI dysmotility
Golden, E. P., & Vernino, S. A. (2024) · Handbook of clinical neurology · doi:10.1016/b978-0-12-823912-4.00005-0 · Cited by 3
Ueno, T., Nakamura, T., Arai, A., Suzuki, C., & Tomiyama, M. (2019) · Neurological Sciences · doi:10.1007/s10072-019-3731-0 · Cited by 2
Decoding Autoimmune Autonomic Disorders: A Less-Recognized Overlap
Mohapatra, P., Agarwal, A., Radhakrishnan, D. M., Srivastava, A. K., & Garg, D. (2024) · Annals of Indian Academy of Neurology · doi:10.4103/aian.aian_394_24 · Cited by 2
Autoimmune and Paraneoplastic Neurological Disorders
Iorio, R., O’Toole, O., & Pittock, S. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398270-4.00029-x · Cited by 2
Self-citationParaneoplastic sensory neuropathy and ganglionic acetylcholine receptor antibody
Dhand, U. K., Sahaya, K., & Singh, N. N. (2011) · Muscle & Nerve · doi:10.1002/mus.22147 · Cited by 2
Exaggerated Autonomic Asymmetry: A Clue to Nutrient Deficiency Dysautonomia
Lonsdale, D., Shamberger, R. J., & Obrenovich, M. E. (2011) · Cited by 2
Paraneoplastic Syndromes of the Nervous System as Complications of Cancer
Rosenfeld, M. R., & Dalmau, J. O. (2017) · Springer eBooks · doi:10.1007/978-3-319-57901-6_13 · Cited by 2
Osuagwu, F. C., Mohiuddin, S. S., & Malas, N. (2018) · Psychosomatics · doi:10.1016/j.psym.2018.07.007 · Cited by 2
Autoantibody Testing in Peripheral Neuropathy
Pestronk, A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6567-6_4 · Cited by 2
Shared Decision‐making in Autoimmune Neurology
Lapides, D. A. (2020) · Neurology Clinical Practice · doi:10.1212/cpj.0000000000000796 · Cited by 3
Autonomic neuropathy as the first presentation of T-cell malignant lymphoma—a case report—
Taguchi, S., Nakamura, T., Yamada, T., Takamido, H., Doyu, M., & Takahashi, A. (2015) · Rinsho Shinkeigaku · doi:10.5692/clinicalneurol.55.29 · Cited by 1
Autonomic nervous system autoimmunity and proposed immunotherapies
Goodman, B. P. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00026-2 · Cited by 1
Kobayashi, S., Yokoyama, S., Maruta, T., Muroyama, A., Yoshikawa, H., & Mitsumoto, Y. (2013) · Advances in Bioscience and Biotechnology · doi:10.4236/abb.2013.46a002 · Cited by 1
Paraneoplastic pandysautonomia as a manifestation of non-small cell lung cancer
Uluç, K., Kocak, M., Koytak, P. K., Borucu, D., Isak, B., Aktan, S., & Us, Ö. (2010) · Neurological Sciences · doi:10.1007/s10072-010-0288-3 · Cited by 1
[Autoimmune autonomic ganglionopathy].
Nakane, S. (2019) · Rinshō shinkeigaku Clinical neurology · doi:10.5692/clinicalneurol.cn-001354
Stauffer, C., Llano, D. A., & Kitten, S. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-240824 · Cited by 1
A Case of a Splitting Headache: Paraneoplastic Rhombencephalitis
Gotera, N., & Schultheis, C. (2022) · Cureus · doi:10.7759/cureus.24302 · Cited by 1
Autonomic failure: Clinicopathologic, physiologic, and genetic aspects
Younger, D. S. (2023) · Handbook of clinical neurology · doi:10.1016/b978-0-323-98818-6.00020-0 · Cited by 1
Subacute-onset paraneoplastic autonomic neuropathy associated with prostate cancer
Muccioli, L., Nicodemo, M., Cortelli, P., & Guarino, M. (2020) · Clinical Autonomic Research · doi:10.1007/s10286-020-00719-9 · Cited by 1
Neurological Complications of Lung Cancer
Chi, M., & Ahluwalia, M. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-57901-6_22 · Cited by 1
Ursini, F., Caio, G., Volta, U., Manfredini, R., & GIORGIO, R. D. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65890-7 · Cited by 1
Autoimmune Autonomic Ganglionopathy
Vernino, S. A., & Low, P. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-386525-0.00100-1
Kovács, L. (2012) · Advances in Neuroimmune Biology · doi:10.3233/nib-2012-012045
A middle-aged woman with nausea, weight loss, and orthostatic hypotension
Singer, W., Yung, I., Wollmann, R. L., Kelly, T. J., & Keegan, B. M. (2011) · Neurology · doi:10.1212/wnl.0b013e318227b18a
Leypoldt, F., Voltz, R., & Hamburg-Eppendorf, U. (2012)
Therapie der immunvermittelten paraneoplastischen neurologischen Erkrankungen
Ayzenberg, I., Gold, R., & Kleiter, I. (2017) · Aktuelle Neurologie · doi:10.1055/s-0043-112741
Paraneoplastic Neurologic Disease
Zalewski, N. L., & Pittock, S. J. (2019) · Springer eBooks · doi:10.1007/978-3-030-16928-2_15
Self-citationAutonomic neuropathies and gastroparesis
Sinn, D.-I., & Jaradeh, S. S. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-818586-5.00010-7
Paraneoplastic neurological disorder syndromes
Diaz‐Arias, L. A., & Probasco, J. C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-69494-0.00020-8
Evaluating the frequency of positive paraneoplastic antibodies and associated malignancy risk
Amin, M., Li, Y., Daly, T. M., & Marquardt, R. J. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117347
Autoimmune dysautonomia secondary to chronic organophosphate exposure
Kanuri, S. H., Shivamurthy, P., Albadareen, R., Elbey, M. A., Gopinathannair, R., & Lakkireddy, D. (2021) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2021.04.012
Zhang, Y., Higuita, L., Barber, M., Pace, A. L. D., & Yeshokumar, A. K. (2021) · Neuroimmunology Reports · doi:10.1016/j.nerep.2021.100036
McKeon, A. B., & Pittock, S. J. (2016) · Wiley eBooks · doi:10.1002/9781118797662.ch10
Self-citationAutoimmune and paraneoplastic neurological disorders
Montalvo, M., Iorio, R., O’Toole, O., & Pittock, S. J. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-85654-6.00047-2
Self-citationNagata, R., Matsuura, E., Nozuma, S., Dozono, M., Noguchi, Y., Ando, M., Hiramatsu, Y., Kodama, D., Tanaka, M., Kubota, R., et al. (2022) · medRxiv · doi:10.1101/2022.10.08.22280876
Stamm, B. J., DiBiase, R., Harris, G. R., Kaprielian, H., Brahmbhatt, N., Wu, A. D., Baker, J. J., & Liotta, E. M. (2022) · Neurology · doi:10.1212/wnl.0000000000201500
Paraneoplastic autonomic dysfunction
McKeon, A. B., & Tracy, J. A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-85492-4.00017-x
Self-citationBaxter, L., Hopkins, S., O’Connor, K. C., Pham, M. C., Nowak, R. J., Monson, N. L., Blackburn, K. M., Hibbs, R. E., Vernino, S. A., & Noviello, C. (2024) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2024.578454
Yamada, K., Inoue, T., Nakamura, S. N., Horiuchi, K., Tsutsumi, Y., Munakata, S., Yagi, S., Fukami, Y., Katsuno, M., & Yabe, I. (2024) · BMC Neurology · doi:10.1186/s12883-024-03879-7
Clinical Reasoning: A 72-Year-Old Man With Progressive Pan-Dysautonomia
Zelikovich, A. S., Schneider, S., Mandal, A. S., Hammer, L. H., & Lancaster, E. (2025) · Neurology · doi:10.1212/wnl.0000000000213994
Neuropathy Associated with Neoplasia
Bilbao, J. M., & Schmidt, R. E. (2014) · Springer eBooks · doi:10.1007/978-3-319-07311-8_16
Sharma, A., Smith, T., Greenlee, J., & Clardy, S. L. (2026) · Handbook of clinical neurology · doi:10.1016/b978-0-323-90887-0.00005-5
Zhang, T., Mills, J. R., Dubey, D., & Klein, C. J. (2026) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2026.111092
Long‐Term Efficacy of Immunotherapy in Autoimmune Autonomic Ganglionopathy—A 10‐Year Follow Up Study
Chiaro, G., Koay, S., Ingle, G. T., McNamara, P., Watson, L. P. E., Bremner, F., & Iodice, V. (2026) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.70421
Malagelada, C., Guarino, M., Bonora, E., Lungaro, L., Barbara, G., Stanghellini, V., & GIORGIO, R. D. (2026) · Autonomic Neuroscience · doi:10.1016/j.autneu.2026.103473
Leto, J., Errington, B., Kline, K., Beadnall, H. N., Barnett, M. H., Spies, J. M., & Urriola, N. (2026) · Practical Neurology · doi:10.1136/pn-2026-005287
Montini, F., Pittock, S. J., Cacciaguerra, L., Weiner, H. L., & Schwerdtfeger, L. (2026) · Annals of Neurology · doi:10.1002/ana.78380
Self-citationSémiologie des fonctions végétatives
Cambier, J., Masson, M., Masson, C., & Dehen, H. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-71451-1.00004-2
Pathologie du système nerveux périphérique
Cambier, J., Masson, M., Masson, C., & Dehen, H. (2012) · Elsevier eBooks · doi:10.1016/b978-2-294-71451-1.00009-1
Metadata
- Authors
- McKeon, A., Lennon, V. A., Lachance, D. H., Fealey, R. D., & Pittock, S. J.
- Affiliations
- Mayo Clinic (US)
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2009-06-01
- Volume
- 66
- Issue
- 6
- Pages
- 735-41
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC3764484
- OpenAlex
- W2166446573
- Cited by
- 168
- References
- 20
- Citations by year
- 2026: 7 · 2025: 2 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 12 · 2020: 9 · 2019: 10 · 2018: 14 · 2017: 9 · 2016: 8 · 2015: 8 · 2014: 8 · 2013: 15 · 2012: 14
- FWCI
- 8.51
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK071209, P01DK068055, R01-DK71209-4, P01-DK-68055)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Autoimmune Neurological Disorders and Treatments
- Health Sciences › Medicine › Clinical Neurology › Myasthenia Gravis and Thymoma
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- immunoglobulins, nicotinic acetylcholine receptors, lung cancer, breast cancer, prostate cancer, autonomic dysfunction, peripheral neuropathy, encephalopathy, autoimmune neurological disorders, cancer screening biomarkers, systemic lupus erythematosus, Sjögren's syndrome
- MeSH terms
- Adenocarcinoma, Aged, Autoantibodies, Autonomic Nervous System Diseases, Encephalitis, Female, Ganglia, Autonomic, Humans, Male, Middle Aged, Neoplasms, Peripheral Nervous System Diseases, Predictive Value of Tests, Receptors, Nicotinic, Retrospective Studies, Biomarkers, Paraneoplastic Syndromes, Nervous System, Primary Dysautonomias
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
